Article
miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients
7 Jun 2022
Abstract excerpt
Cholangiocarcinoma (CCA) is one of the most common hepatic and biliary malignancies. The overall five-year survival rate for cholangiocarcinoma is less than 15%. miR-28-5p has been reported to participate the development of various human cancer types. But whether miR-28-5p is associated with the clinical course of CCA patients has not been clarified. Herein, we observed that miR-28-5p was reduced in CCA tissues...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
